The estimated Net Worth of Richard Giltner is at least 8.51 百万$ dollars as of 13 July 2024. Mr. Giltner owns over 1,800 units of United Therapeutics Corp stock worth over 6,030,630$ and over the last 16 years he sold UTHR stock worth over 2,032,376$. In addition, he makes 451,256$ as Independent Director at United Therapeutics Corp.
Richard has made over 37 trades of the United Therapeutics Corp stock since 2010, according to the Form 4 filled with the SEC. Most recently he exercised 1,800 units of UTHR stock worth 623,142$ on 13 July 2024.
The largest trade he's ever made was exercising 20,000 units of United Therapeutics Corp stock on 25 September 2014 worth over 620,800$. On average, Richard trades about 4,141 units every 99 days since 2009. As of 13 July 2024 he still owns at least 17,420 units of United Therapeutics Corp stock.
You can see the complete history of Mr. Giltner stock trades at the bottom of the page.
Richard A. Giltner serves as Independent Director of the Company. From 2009 until his retirement in 2010, Mr. Giltner was a portfolio manager at Lyxor Asset Management, an asset management group at the French bank Société Générale. From 2006 until 2009, he served as a managing director of Société Générale Asset Management, an international fund management firm, and head of the European office for its fund of hedge funds group. From 2003 to 2006, Mr. Giltner was the global head of foreign exchange options for the investment banking arm of Société Générale. He also held various other managerial positions within Société Générale from 1991 until 2003. Mr. Giltner has been a private investor since his retirement from Société Générale in 2010. Our Board of Directors has determined that Mr. Giltner is an audit committee financial expert as defined under the rules and regulations of the SEC and meets the financial sophistication requirements of Nasdaq's listing standards. Mr. Giltner has served as a United Therapeutics director since 2009.
As the Independent Director of United Therapeutics Corp, the total compensation of Richard Giltner at United Therapeutics Corp is 451,256$. There are 12 executives at United Therapeutics Corp getting paid more, with Martine Rothblatt having the highest compensation of 15,627,500$.
Richard Giltner is 56, he's been the Independent Director of United Therapeutics Corp since 2009. There are 14 older and 5 younger executives at United Therapeutics Corp. The oldest executive at United Therapeutics Corp is Louis Sullivan, 86, who is the Independent Director.
Richard's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.
Over the last 20 years, insiders at United Therapeutics Corp have traded over 68,910,395$ worth of United Therapeutics Corp stock and bought 229,703 units worth 13,655,671$ . The most active insiders traders include Martine A Rothblatt、David Zaccardelli、Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of 2,310,818$. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth 991,341$.
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
United Therapeutics Corp executives and other stock owners filed with the SEC include: